Medicare Part DNCT02241980
Survey of Patient and Physician Knowledge and Perception Regarding Medicare Part D Plan Selection
An observational study of Medicare Part D, run by Ohio State University at 1 site in United States.
Trial summary
Evaluation of patients' methodology and ability to select an economical and ideal Medicare Part D prescription drug plan (PDP). Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Medicare Part D
- What is being tested?
- Patient survey and Physician survey
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- Aug 2014to Oct 2014
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Study population: Patients of Martha Morehouse General Internal Medicine Clinic at the Ohio State University Wexner Medical Center
Who may be able to join
- Patient of Martha Morehouse General Internal Medicine Clinic at the Ohio State University Wexner Medical Center
- Medicare A/B is listed as primary insurance
- Patients 65 years old or older
- Physicians of Martha Morehouse General Internal Medicine Clinic at the Ohio State University Wexner Medical Center
Who cannot join
- Patients less than the age of 65 years old
- Patients with Medicare Advantage plan
- Physician Population
Trial locations and contacts
1 site in 1 country.
United States1 site
Martha Morehouse Internal Medicine Clinic at Ohio State University Wexner Medical Center
Columbus, Ohio, 43221
About this study
Evaluation of patients' methodology and ability to select an economical and ideal Medicare Part D prescription drug plan (PDP).
Read the detailed description
The purpose of this project is to evaluate patients' methodology and ability to select an economical and ideal Medicare Part D prescription drug plan (PDP).
The primary objective of this project is to determine the percentage of patients who are enrolled in Medicare Part D who are currently enrolled in their ideal plan based on estimated costs.Secondary objectives are to determine:
- The percentage of patients who have switched or considered switching their Medicare Part D PDP at any point during their enrollment
- The most commonly used resources used by beneficiaries to aid in selection of a Medicare Part D PDP
- The percentage of patients who reach the Medicare Part D donut hole as a result of their current plan
- Physician perception of appropriate selection of Medicare Part D PDP among their patient panel
- Physician perception of administrative time spent resolving medication issues related to Medicare Part D PDPs
- Conditions
- Medicare Part D
- Being tested
- Patient survey, Physician survey
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patient surveyOther
Physician surveyOther
| Study group | Role | What they receive |
|---|---|---|
| Medicare Part D patients | Survey Receives: Other: Patient survey | |
| Physician Providers | Survey Receives: Other: Physician survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
The percentage of patients who are enrolled in Medicare Part D who are currently enrolled in their ideal plan based on estimated costs
Measured: Within 9 weeks of beginning survey
Secondary outcomes (5)
The percentage of patients who have switched or considered switching their Medicare Part D PDP at any point during their enrollment
Measured: Within 9 weeks of beginning survey
The most commonly used resources used by beneficiaries to aid in selection of a Medicare Part D PDP
Measured: Within 9 weeks of beginning survey
The percentage of patients who reach the Medicare Part D donut hole as a result of their current plan
Measured: Within 9 weeks of beginning survey
Physician perception of appropriate selection of Medicare Part D PDP among their patient panel
Measured: Within 9 weeks of beginning survey
Physician perception of administrative time spent resolving medication issues related to Medicare Part D PDPs
Measured: Within 9 weeks of beginning survey
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2014 (estimated)
- Study startAug 2014
- Primary completionOct 2014 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medicare Part DStudies of the same condition, open and under way.
- More trials run by Ohio State UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ohio State University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Stuart Beatty, Ohio State University
- Investigators
- Stuart Beatty, PharmD, Principal investigator, Ohio State University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02241980
- Sponsor's protocol ID
- 2014H0191
- Status last verified
- Sep 2022
- First submitted
- 9 Sep 2014
- Last updated
- 29 Sep 2022
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Sep 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Survey of Patient and Physician Knowledge and Perception Regarding Medicare Part D Plan Selection
- ClinicalTrials.gov ID
- NCT02241980
- Acronym / sponsor ID
- 2014H0191
- Conditions
- Medicare Part D
- Study type
- Observational
- Recruitment status
- Withdrawn
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Ohio State UniversityUniversity, hospital or other
- Study start
- Aug 2014
- Primary completion
- Oct 2014 (estimated)
- First posted
- 16 Sep 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Evaluation of patients' methodology and ability to select an economical and ideal Medicare Part D prescription drug plan (PDP).
Detailed description
The purpose of this project is to evaluate patients' methodology and ability to select an economical and ideal Medicare Part D prescription drug plan (PDP).
The primary objective of this project is to determine the percentage of patients who are enrolled in Medicare Part D who are currently enrolled in their ideal plan based on estimated costs.Secondary objectives are to determine:
- The percentage of patients who have switched or considered switching their Medicare Part D PDP at any point during their enrollment
- The most commonly used resources used by beneficiaries to aid in selection of a Medicare Part D PDP
- The percentage of patients who reach the Medicare Part D donut hole as a result of their current plan
- Physician perception of appropriate selection of Medicare Part D PDP among their patient panel
- Physician perception of administrative time spent resolving medication issues related to Medicare Part D PDPs
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Medicare Part D patients | – | Other: Patient surveySurvey |
| Physician Providers | – | Other: Physician surveySurvey |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
- Study population
- Patients of Martha Morehouse General Internal Medicine Clinic at the Ohio State University Wexner Medical Center
Key inclusion criteria (4 listed)
- Patient of Martha Morehouse General Internal Medicine Clinic at the Ohio State University Wexner Medical Center
- Medicare A/B is listed as primary insurance
- Patients 65 years old or older
- Physicians of Martha Morehouse General Internal Medicine Clinic at the Ohio State University Wexner Medical Center
Key exclusion criteria (3 listed)
- Patients less than the age of 65 years old
- Patients with Medicare Advantage plan
- Physician Population
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Patient survey | Other | Medicare Part D patients |
| Physician survey | Other | Physician Providers |
Primary outcome
The percentage of patients who are enrolled in Medicare Part D who are currently enrolled in their ideal plan based on estimated costs
Time frame: Within 9 weeks of beginning survey
5 secondary outcomes
The percentage of patients who have switched or considered switching their Medicare Part D PDP at any point during their enrollment
Time frame: Within 9 weeks of beginning survey
The most commonly used resources used by beneficiaries to aid in selection of a Medicare Part D PDP
Time frame: Within 9 weeks of beginning survey
The percentage of patients who reach the Medicare Part D donut hole as a result of their current plan
Time frame: Within 9 weeks of beginning survey
Physician perception of appropriate selection of Medicare Part D PDP among their patient panel
Time frame: Within 9 weeks of beginning survey
Physician perception of administrative time spent resolving medication issues related to Medicare Part D PDPs
Time frame: Within 9 weeks of beginning survey
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Sep 2022.
Related trials for Medicare Part D
Active, not recruiting
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
Autoimmune Diseases, Rheumatoid Arthritis (RA)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Stuart Beatty, PharmD principal investigator
Ohio State University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Medicare Part D, run by Ohio State University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 29 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The percentage of patients who are enrolled in Medicare Part D who are currently enrolled in their ideal plan based on estimated costs (time frame: Within 9 weeks of beginning survey). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2022.